Private Medical Cannabis Prescription Costs in the UK: What Patients Actually Pay

Why Medical Cannabis Is a Private Prescription

• Despite being legal and licensed in the UK since November 2018, medical cannabis is rarely prescribed on the NHS
• NHS England has restricted cannabis prescribing to three specific indications: childhood epilepsy (Epidyolex), MS spasticity (Sativex), and chemotherapy-induced nausea (nabilone)
• For all other indications — chronic pain, anxiety, insomnia, PTSD — patients must access cannabis privately
• The private prescribing market has grown rapidly, with competition driving prices down significantly since 2019
• Pharmacy dispensing costs are set by the dispensing pharmacy and vary by product

The shift of medical cannabis to private prescribing is a consequence of NHS conservatism around controlled drugs and the limited clinical trial evidence base acceptable to NICE. For the majority of patients, this means bearing the full cost themselves. Understanding the cost structure helps patients budget accurately and compare options effectively.

Consultation and Clinic Fees

• Initial consultation: £50–£200 depending on clinic and clinician seniority
• Follow-up appointments (required every 1–3 months): £30–£100
• Some clinics offer annual memberships — reducing per-appointment costs
• Telehealth appointments are generally cheaper than in-person — no clinic overheads
• Some clinics offer free initial assessments to determine eligibility before charging

Consultation fees represent the more predictable element of medical cannabis costs. Budget for approximately £100–£200 in the first year for consultations alone, assuming quarterly reviews. Many patients find that as their treatment stabilises, the review interval extends — reducing annual consultation costs over time.

Medication Costs: Flower, Oils, and Capsules

• Dried flower (per gram): £6–£15 depending on origin, cultivar, and THC/CBD content
• Monthly flower costs for typical patients: £60–£200 for 10–25g/month
• Sublingual oils: £40–£120 per 10ml bottle (30-day supply at moderate doses)
• Capsules: typically £80–£150 per 60-capsule pack (30-day supply)
• Full-spectrum or rare cultivars command a premium over standard products

Medication costs are the largest ongoing expense for most patients. The wide price range reflects significant differences between manufacturers, formulations, and retail markups. EU-GMP certified products from established manufacturers (including Cannamedical’s UK-destined products) are typically priced at a premium over lower-certification alternatives — but the quality differential justifies the cost for patients who depend on consistency.

Total Monthly Costs and How to Reduce Them

• Average total monthly cost for a typical patient: £150–£350 including medication and pro-rated consultation fees
• Patients with higher symptom burden or specialist formulation needs may pay £400+
• Comparison shopping between dispensing pharmacies is allowed and advisable — prices vary significantly
• Some clinics offer loyalty discounts, referral incentives, or hardship support
• Regular prescription reviews to minimise dose — particularly as symptoms improve — reduces cost

Medical cannabis is a significant ongoing financial commitment for most patients. The most effective cost reduction strategies are comparison shopping between dispensaries, maintaining regular reviews to optimise (not maximise) your dose, and engaging with your clinic’s patient support team if costs are becoming prohibitive. As the UK market continues to grow and competition intensifies, prices are expected to continue falling.